Burning Rock Biotech (BNR) Leases: 2019-2025
Historic Leases for Burning Rock Biotech (BNR) over the last 4 years, with Sep 2025 value amounting to $4.5 million.
- Burning Rock Biotech's Leases fell 67.96% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 67.96%. This contributed to the annual value of $7.3 million for FY2024, which is 321.21% up from last year.
- Burning Rock Biotech's Leases amounted to $4.5 million in Q3 2025, which was down 89.65% from $43.8 million recorded in Q1 2025.
- In the past 5 years, Burning Rock Biotech's Leases registered a high of $58.4 million during Q3 2022, and its lowest value of $1.7 million during Q4 2023.
- In the last 3 years, Burning Rock Biotech's Leases had a median value of $14.3 million in 2024 and averaged $18.0 million.
- Per our database at Business Quant, Burning Rock Biotech's Leases tumbled by 93.08% in 2024 and then surged by 1,509.26% in 2025.
- Burning Rock Biotech's Leases (Quarterly) stood at $12.7 million in 2021, then tumbled by 45.02% to $7.0 million in 2022, then crashed by 75.25% to $1.7 million in 2023, then spiked by 321.21% to $7.3 million in 2024, then tumbled by 67.96% to $4.5 million in 2025.
- Its Leases stands at $4.5 million for Q3 2025, versus $43.8 million for Q1 2025 and $7.3 million for Q4 2024.